Uncategorized

Clinakos is live at booth #54 at Reuters Pharma USA 2025 March 18, 2025 🚀 WE ARE LIVE NOW! We’ve landed at Booth #54 at Reuters Events Pharma USA 2025 in Philadelphia! Join us to meet our team and experience the future of life sciences with Clinakos Inc. Discover how we’re redefining healthcare through innovation. […]

Multiple Myeloma Awareness Month March 13, 2025 As we mark Multiple Myeloma Awareness Month, we’re excited to highlight the groundbreaking advancements in therapies transforming patient care in the U.S. Recent breakthroughs include monoclonal antibodies, which have significantly improved outcomes when combined with standard therapies. CAR T-cell therapies offer personalized treatment options for relapsed or refractory

Clinakos will be exhibiting at Reuters Pharma USA 2025 March 18, 2025 We are thrilled to announce that Clinakos Inc. will be exhibiting at Reuters Events Pharma USA 2025! This is a unique opportunity to learn about how Clinakos is transforming the life sciences sector with its pioneering Integrated Patient Data™ and Medically Smart AI™.

Meet us at MAPS 2025 March 18, 2025 We’re excited to announce our participation in the upcoming MAPS Annual Conference, taking place from March 23 – 26, 2025, in New Orleans. This event presents an excellent opportunity to connect with clients, partners, and collaborators. We look forward to engaging in insightful discussions on groundbreaking solutions

February 28 is Rare Disease Day March 18, 2025 💡 Rare diseases disproportionately affect children, with a staggering two-thirds of American rare disease patients being kids. This sobering statistic underscores the critical importance of early detection and intervention – a mission that drives us at Clinakos Inc. Meet Anthony, whose story, shared by National Organization

Rare Disease Month February January 30, 2025 As Rare Disease Month approaches this February, we turn our attention to the extraordinary stories of individuals navigating life with conditions that often defy quick diagnosis and straightforward treatment. Their journeys are a testament to resilience and the urgent need for innovation. Recently, I came across with the

Meet Us at SCOPE 2025 February 28, 2025 With over 4,500 attendees and 1,200 organizations from 30 countries coming together in clinical operations, innovation, and digital health, SCOPE 2025 promises to be a game-changer for the industry. The 2025 agenda has been expanded to provide deeper coverage of Patient-Centric Trial Design, Generative AI, Small Biopharma

43rd Annual J.P Morgan Annual Healthcare Conference January 14, 2025 The energy is incredible—packed meetings, buzzing lobbies, and excitement everywhere! Key themes taking center stage:✨ Rare diseases and gene therapy, especially in immunology, are generating huge buzz.💡 Optimism about the IPO window reopening is energizing conversations.🤝 Deal activity is anticipated to pick up momentum.🏛️ Policy

22nd Orphan Drugs & Rare Diseases Global Congress 2024 Americas – Copy January 14, 2025 How Patient Data and AI are Revolutionizing Rare Disease Drug Development and Commercialization ✨The power of patient data and AI is reshaping how pharmaceutical companies approach drug development & commercialization—enabling unprecedented precision and speed. Imagine targeting the right patient population

Join Clinakos Inc. and Rare Patient Voice on February 4, 2025 January 2, 2025 Join Clinakos Inc. and Rare Patient Voice on February 4, 2025, for an engaging webinar:“Accelerating Rare Disease Drug Development and Commercialization: Bridging Data Gaps with Integrated Patient Data™ & AI.” Did you know it often takes years for rare disease patients